Schedule 13G ownership disclosure

Lipocine Inc.

Security class unavailable · CUSIP: 53630X104

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
187,221
Percent of class
1.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000117
Form type
SC 13G
Filer
Lipocine Inc.
CIK
CIK 1535955
Filed
Jan 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub